Abvc corporate update and ceo's letter to shareholders

Fremont, ca, aug. 07, 2023 (globe newswire) -- via newmediawire - abvc biopharma, inc. (nasdaq: abvc) ("company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, today published a corporate update and letter to shareholders from recently appointed chief executive officer, dr. uttam patil.

ABVC Ratings Summary

ABVC Quant Ranking